Search
Acylcarnitine 10-MethylHexadecanoylcarnitine
smpdb.ca/view/SMP0123651Metabolic10-MethylHexadecanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-methylhexadecanoyl-CoA reacts with L-carnitine to form 10-methylhexadecanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-methylnonadecanoylcarnitine
smpdb.ca/view/SMP0123692Metabolic10-methylnonadecanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-methylnonadecanoyl-CoA reacts with L-carnitine to form 10-methylnonadecanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-Methylicosanoylcarnitine
smpdb.ca/view/SMP0123707Metabolic10-Methylicosanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-methylicosanoyl-CoA reacts with L-carnitine to form 10-methylicosanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-Methyldocosanoylcarnitine
smpdb.ca/view/SMP0123749Metabolic10-Methyldocosanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-methyldocosanoyl-CoA reacts with L-carnitine to form 10-methyldocosanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-Methyltetracosanoylcarnitine
smpdb.ca/view/SMP0123790Metabolic10-Methyltetracosanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-methyltetracosanoyl-CoA reacts with L-carnitine to form 10-methyltetracosanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-hydroxyhexadecanoylcarnitine
smpdb.ca/view/SMP0124256Metabolic10-hydroxyhexadecanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-hydroxyhexadecanoyl-CoA reacts with L-carnitine to form 10-hydroxyhexadecanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-hydroxyheptadecanoylcarnitine
smpdb.ca/view/SMP0124305Metabolic10-hydroxyheptadecanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-hydroxyheptadecanoyl-CoA reacts with L-carnitine to form 10-hydroxyheptadecanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine 10-Hydroxyoctadecanoylcarnitine
smpdb.ca/view/SMP0124311Metabolic10-Hydroxyoctadecanoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, 10-hydroxyoctadecanoyl-CoA reacts with L-carnitine to form 10-hydroxyoctadecanoylcarnitine. This reaction is catalyzed by carnitine O-palmitoyltransferase.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreCeritinib
go.drugbank.com/drugs/DB09063ApprovedInvestigationalCeritinib is used for the treatment of adults with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) following failure (secondary to resistance or intolerance) of prior crizotinib therapy. About 4% o...
Categories: Heterocyclic Compounds, 1-RingProducts: ZYKADIA 150 MG, ZYKADIA 150 MG KAPSÜL, 150 ADETPeginterferon alfa-2a
go.drugbank.com/drugs/DB00008ApprovedInvestigationalPeginterferon alfa-2a is derived from the alfa-2a moeity of recombinant human interferon and acts by binding to human type 1 interferon receptors. … When combined together, Peginterferon alfa-2a and [DB00811] have been shown to achieve a SVR between 36% for genotype 1 and 59% for genotypes 2-6 after 48 weeks of treatment.
Products: PEGASYS 180 MCG/0.5 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ŞIRINGA, 1 ADET, PEGASYS PRE-FILLED SYRINGE FOR INJECTION 180 mcg/0.5 ml